Cargando…
Focusing in on use of pharmacokinetic profiles in routine hemophilia care
BACKGROUND: Emergence of population pharmacokinetic models for prediction of individual pharmacokinetic (PK) profiles facilitates individualization of prescribed prophylactic therapy for patients with hemophilia A and B and may have a favorable impact on clinical outcomes and annual factor utilizati...
Autores principales: | Croteau, Stacy E., Callaghan, Michael U., Davis, Joanna, Dunn, Amy L., Guerrera, Michael, Khan, Osman, Neufeld, Ellis J., Raffini, Leslie J., Recht, Michael, Wang, Michael, Iorio, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046597/ https://www.ncbi.nlm.nih.gov/pubmed/30046766 http://dx.doi.org/10.1002/rth2.12118 |
Ejemplares similares
-
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
por: Iorio, Alfonso, et al.
Publicado: (2018) -
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
por: Yu, Jacky K., et al.
Publicado: (2019) -
Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes
por: Croteau, Stacy E., et al.
Publicado: (2020) -
PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW
por: Al-Housni, Zainab, et al.
Publicado: (2023) -
A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)
por: Konkle, Barbara A, et al.
Publicado: (2021)